CN Patent

CN102406938A — 一种抗血栓的药物组合物

Assigned to Beijing Fukangren Bio Pharm Tech Co Ltd · Expires 2012-04-11 · 14y expired

What this patent protects

本发明为一种抗血栓药物组合物，是以阿司匹林或三氟柳和一种具有抗血小板活性的药物、一种可抑制胃酸生成的药物为活性成分，与药学上适宜的辅料组合而成。本发明所述的组合物可制成口服制剂，用于治疗和/或预防各种心脑血管事件的发生。

USPTO Abstract

本发明为一种抗血栓药物组合物，是以阿司匹林或三氟柳和一种具有抗血小板活性的药物、一种可抑制胃酸生成的药物为活性成分，与药学上适宜的辅料组合而成。本发明所述的组合物可制成口服制剂，用于治疗和/或预防各种心脑血管事件的发生。

Drugs covered by this patent

Patent Metadata

Patent number
CN102406938A
Jurisdiction
CN
Classification
—
Expires
2012-04-11
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.